Oncogene withdrawal engages the immune system to induce sustained cancer regression
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2051-1426
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Oncogene withdrawal engages the immune system to induce sustained cancer regression ; volume:2 ; number:1 ; day:15 ; month:7 ; year:2014 ; pages:1-8 ; date:12.2014
Journal for ImmunoTherapy of Cancer ; 2, Heft 1 (15.7.2014), 1-8, 12.2014
- Creator
-
Casey, Stephanie C.
- Contributor
-
Li, Yulin
Fan, Alice C.
Felsher, Dean W.
SpringerLink (Online service)
- DOI
-
10.1186/2051-1426-2-24
- URN
-
urn:nbn:de:1111-2016072656142
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:50 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Casey, Stephanie C.
- Li, Yulin
- Fan, Alice C.
- Felsher, Dean W.
- SpringerLink (Online service)
Other Objects (12)
Tumor regression mediated by oncogene withdrawal or erlotinib stimulates infiltration of inflammatory immune cells in EGFR mutant lung tumors
Oncogene : including Oncogene reviews
CDK4/6 inhibitors induce replication stress to cause long‐term cell cycle withdrawal
A mathematical model of tumor regression and recurrence after therapeutic oncogene inactivation
Partial p53 reactivation is sufficient to induce cancer regression
Epigenome editing to induce sustained modulation of Immune checkpoints' expression in CAR T cells
Tissue-Engineered Endothelial Cells Induce Sustained Vascular Healing Through Early Induction of Vascular Repair
Combination therapy using TGF-β1 and STI-571 can induce apoptosis in BCR-ABL oncogene-expressing cells
CDK5: an oncogene or an anti-oncogene: location location location
TLR agonists induce sustained IgG to hemagglutinin stem and modulate T cells following newborn vaccination
Organometallic nucleosides induce non-classical leukemic cell death that is mitochondrial-ROS dependent and facilitated by TCL1-oncogene burden
Organometallic nucleosides induce non-classical leukemic cell death that is mitochondrial-ROS dependent and facilitated by TCL1-oncogene burden
Tumor regression mediated by oncogene withdrawal or erlotinib stimulates infiltration of inflammatory immune cells in EGFR mutant lung tumors
Oncogene : including Oncogene reviews
CDK4/6 inhibitors induce replication stress to cause long‐term cell cycle withdrawal
A mathematical model of tumor regression and recurrence after therapeutic oncogene inactivation
Partial p53 reactivation is sufficient to induce cancer regression
Epigenome editing to induce sustained modulation of Immune checkpoints' expression in CAR T cells
Tissue-Engineered Endothelial Cells Induce Sustained Vascular Healing Through Early Induction of Vascular Repair
Combination therapy using TGF-β1 and STI-571 can induce apoptosis in BCR-ABL oncogene-expressing cells
CDK5: an oncogene or an anti-oncogene: location location location
TLR agonists induce sustained IgG to hemagglutinin stem and modulate T cells following newborn vaccination
Organometallic nucleosides induce non-classical leukemic cell death that is mitochondrial-ROS dependent and facilitated by TCL1-oncogene burden
Organometallic nucleosides induce non-classical leukemic cell death that is mitochondrial-ROS dependent and facilitated by TCL1-oncogene burden
Tumor regression mediated by oncogene withdrawal or erlotinib stimulates infiltration of inflammatory immune cells in EGFR mutant lung tumors
Oncogene : including Oncogene reviews
CDK4/6 inhibitors induce replication stress to cause long‐term cell cycle withdrawal
A mathematical model of tumor regression and recurrence after therapeutic oncogene inactivation
Partial p53 reactivation is sufficient to induce cancer regression
Epigenome editing to induce sustained modulation of Immune checkpoints' expression in CAR T cells
Tissue-Engineered Endothelial Cells Induce Sustained Vascular Healing Through Early Induction of Vascular Repair
Combination therapy using TGF-β1 and STI-571 can induce apoptosis in BCR-ABL oncogene-expressing cells
CDK5: an oncogene or an anti-oncogene: location location location
TLR agonists induce sustained IgG to hemagglutinin stem and modulate T cells following newborn vaccination
Organometallic nucleosides induce non-classical leukemic cell death that is mitochondrial-ROS dependent and facilitated by TCL1-oncogene burden